January 7, 2021

A significant risk factor for heart failure, diabetes is a common debilitating comorbidity. New emerging therapies and a better understanding of this comorbid condition can assist clinicians in improving care and outcomes for these patients. JACC: Heart Failure is focusing on the growing body of literature with a special issue on this topic planned for August of 2021. Submissions are due on or before April 2, 2021. Topics spanning this focus are welcome, including epidemiology, diagnosis and prognosis, short- and long-term outcomes, clinical management, phenotyping, emerging therapies, the role of biomarkers, and other relevant issues. Learn more on JACC.org.